NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/20/2024
Back to search
Official data from USPTO
TERGUS PHARMA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
TERGUS PHARMA
ST13
US500000098020216Class
40
Filing
98020216
Registration
7478549
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
15
Latest update
08/20/2024
Classification
Registered
Trademark type
Word
Nice classes
40
Filing date
05/31/2023
Registration date
08/20/2024
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/20/2024
Last transaction
08/20/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
08/31/2012
First use in commerce
08/31/2012
Drawing code
4
Owner type
16
Owner location
Durham, NC
Examiner
TENG, SIMON
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Tergus Pharma, LLC
Representatives
David Postolski GEARHART LAW
Technical classification
Nice Classes
Class 40
Vienna Codes
No Vienna codes available.
Goods and services
Class 40
Contract manufacturing services in the field of pharmaceutical preparationsdermatologicals or topicals in the form of semi-solidscreamsoilsointmentsgelslotionsliquidspastesfoamssprays for use in the treatment of skinhairnailsophthalmicoticvaginalskinhairnaileyeearvaginal disorders and/or for delivery through skin into systemic circulation for other disorders; Contract manufacturing services in the field of pharmaceutical preparations for topical and transdermal applicationscreamsoilsointmentsgelslotionsliquidspastesfoamssprays for the treatment of skinhairnailsophthalmicoticvaginal and skinhairnaileyeearvaginal disorders
Publications
History of USPTO decisions and trademark events.
15 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/04/2024
PUBO
PUBLISHED FOR OPPOSITION
06/04/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
05/15/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
05/01/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/25/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/25/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/23/2024
GNRT
NON-FINAL ACTION E-MAILED
02/23/2024
CNRT
NON-FINAL ACTION WRITTEN
02/23/2024
DOCK
ASSIGNED TO EXAMINER
02/23/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/30/2023
NWAP
NEW APPLICATION ENTERED
06/03/2023
Continuous trademark protection
Get notified about every new filing that threatens TERGUS PHARMA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.